Chilblain-like lesions and COVID-19 infection: A prospective observational study at Spain's ground zero
暂无分享,去创建一个
E. López-Granados | V. Jiménez‐Yuste | J. Rodríguez-Peralto | M. Alonso-Riaño | A. Nuno-Gonzalez | A. Enguita | P. Nozal | E. Ruíz-Bravo | M. Feito-Rodríguez | Luz Yadira Bravo-Gallego | P. Herranz‐Pinto | C. Cámara-Hijón | A. Mayor-Ibarguren | R. de Lucas-Laguna | Dolores Montero-Vega | Marí Granados-Fernández | G. Servera‐Negre | Celia Fernández-Alcalde | Á. Fernández-Heredero
[1] J. Rodríguez-Peralto,et al. SARS‐CoV‐2 endothelial infection causes COVID‐19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases , 2020, The British journal of dermatology.
[2] C. Chiaverini,et al. Negative SARS-CoV-2 PCR in patients with chilblain-like lesions , 2020, The Lancet Infectious Diseases.
[3] C. Rice,et al. Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals , 2020, Nature.
[4] Jean Kanitakis,et al. Chilblain-like acral lesions during the COVID-19 pandemic (“COVID toes”): Histologic, immunofluorescence, and immunohistochemical study of 17 cases , 2020, Journal of the American Academy of Dermatology.
[5] J. Lipoff,et al. The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries , 2020, Journal of the American Academy of Dermatology.
[6] Akihide Ryo,et al. Interpreting Diagnostic Tests for SARS-CoV-2. , 2020, JAMA.
[7] A. Torrelo,et al. Erythema multiforme‐like lesions in children and COVID‐19 , 2020, Pediatric dermatology.
[8] L. Joosten,et al. Trained Immunity and Local Innate Immune Memory in the Lung , 2018, Cell.
[9] Emanuel Schenck,et al. Formation, Clearance, Deposition, Pathogenicity, and Identification of Biopharmaceutical-related Immune Complexes , 2014, Toxicologic pathology.